Table 2.

Immune responses at Pre IT, Pre SCT and 3–6 Months Post SCT.

Immune Response	Time Intervals	IT20007	IT20017	IT20020	IT20031	Total # (%) of positive responses in boosted patients
CTL	PreIT	+	-	-	±	1/4 (25)
	PreSCT	++	++	+	+++	4/4 (100)
	3–6 M PostSCT	++	+/-	+	+++	3/4(100)
IFNγ	PreIT	++	++	+/-	+/-	2/4 (50)
	PreSCT	++	++	+	+	4/4 (100)
	3–6 M PostSCT	+++	-	+	++	3/4 (75)
Serum Ab	PreIT	+	+/-	+/-	+	2/4 (50)
	PreSCT	++	+/-	+/-	++	2/4 (50)
	3–6 M PostSCT	++	+/-	+	++	3/4 (75)
In Vitro Ab Synthesis	PreIT	+/-	+	+	+	3/4 (75)
	PreSCT	+++	+	++	++	4/4 (100)
	3–6 M PostSCT	++	+/-	++	++	3/4 (75)
Th1	PreIT	+	+	+	+	4/4 (100)
	PreSCT	+++	+++	+++	+++	4/4 (100)
	3–6 M PostSCT	+++	+++	++	++	4/4 (100)
Th2	PreIT	+	+	+/-	+/-	2/4 (100)
	PreSCT	+++	++	+	+	4/4 (100)
	3–6 M PostSCT	+	+++	+/-	+/-	2/4 (100)
Cell Dose (x 109)		39.8	59.9	16.4	41.6
Survival (months)		35.5	5.9	34.3	59.8